Activation of the JAK-STAT pathway by reactive oxygen species

American Journal of Physiology - Cell Physiology

Volumn 275, Issue 6 44-6, 1998, Pages

  Simon, Amy R ^a   Rai, Usha ^b   Fanburg, Barry L ^a   Cochran, Brent H ^b  

^a TUFTS MEDICAL CENTER   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Hydrogen peroxide; Platelet derived growth factor; TYK2

Indexed keywords

HYDROGEN PEROXIDE; PLATELET DERIVED GROWTH FACTOR; REACTIVE OXYGEN METABOLITE; STAT1 PROTEIN; STAT3 PROTEIN; TRANSCRIPTION FACTOR;

ADULT RESPIRATORY DISTRESS SYNDROME; ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; ENZYME ACTIVATION; LUNG FIBROSIS; NONHUMAN; ONCOGENE C FOS; ONCOGENE C MYC; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN FAMILY; RAT;

ANIMALIA; MAMMALIA;

EID: 0032416113     PISSN: 03636143     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpcell.1998.275.6.c1640     Document Type: Article

References (18)

1. Amstad, P.A., G. Krupitza, and P. A. Cerutti. Mechanism of c-fos induction by active oxygen. Cancer Res. 52: 3952-3960, 1992.
2. Bae, Y. S., S. W. Kang, M. S. Seo, I. C. Baines, E. Tekle, P. B. Chock, and S. G. Rhee. Epidermal growth factor (EGF)-induced generation of hydrogen peroxide. Role in EGF receptor-mediated tyrosine phosphorylation. J. Biol. Chem. 272: 217-221, 1997.
3. Baeuerle, P. A., and D. Baltimore. I-KB: a specific inhibitor of the NF-KB transcription factor. Science 242: 540-546, 1988.
4. Behl, C., J. B. Davis, R. Lesley, and D. Schubert. Hydrogen peroxide mediates amyloid beta protein toxicity. Cell 77: 817-827, 1994.
5. Bernier, M., A. Liotta, H. Kole, D. Shock, and J. Roth. Dynamic regulation of intact and C-terminal truncated insulin receptor phosphorylation in permeabilized cells. Biochemistry 33: 4343-4351, 1994.
6. 2: senescence-like growth arrest or apoptosis? Cell Growth Differ. 8: 589-598, 1997.
7. Bonni, A., D. A. Frank, C. Schindler, and M. E. Greenberg. Characterization of a pathway for ciliary neurotrophic factor signaling to the nucleus. Science 262: 1575-1579, 1993.
8. Bromberg, J. F., C. M. Horvath, D. Besser, W. W. Lathem, and J. E. Darnell, Jr. Stat3 activation is required for cellular transformation by v-src. Mol. Cell. Biol. 18: 2553-2558, 1998.
9. Caldenhoven, E., T. B. van Dijk, R. Solari, J. Armstrong, J. A. M. Raaijmakers, J. W. J. Lammers, L. Koenderman, and R. P. de Groot. STAT3β, a splice variant of transcription factor STAT3, is a dominant negative regulator of transcription. J. Biol. Chem. 271: 13221-13227, 1996.
10. Chang, M., M. Shi, and H. J. Forman. Exogenous glutathione protects endothelial cells from menadione toxicity. Am. J. Physiol. 262 (Lung Cell. Mol. Physiol. 6): L637-L643, 1992.
11. Chin, Y. E., M. Kitagawa, K. Kuida, R. A. Flavell, and X. Y. Fu. Activation of the STAT signaling pathway can cause expression of caspase 1 and apoptosis. Mol. Cell. Biol. 17: 5328-5337, 1997
12. WAF1/CIP1 mediated by STAT1. Science 272: 719-722, 1996.
13. Chung, J., E. Uchida, T. C. Grammer, and J. Blenis. STAT3 serine phosphorylation by ERK-dependent and -independent pathways negatively modulates its tyrosine phosphorylation. Mol. Cell. Biol. 17: 6508-6516, 1997.
14. Darnell, J. E., Jr. STATs and gene regulation. Science 277: 1630-1635, 1997.
15. David, M., H. E. Chen, S. Goelz, A. C. Larner, and B. G. Neel. Differential regulation of the α/β interferon-stimulated Jak/Stat pathway by the SH2 domain-containing tyrosine phosphatase SHPTP1. Mol. Cell. Biol. 15: 7050-7058, 1995.
16. David, M., P. M. Grimley, D. S. Finbloom, and A. C. Larner. A nuclear tyrosine phosphatase downregulates interferon-induced gene expression. Mol. Cell. Biol. 13: 7515-7521, 1993.
17. David, M., G. Romero, Z. Y. Zhang, J. E. Dixon, and A. C. Larner. In vitro activation of the transcription factor ISGF3 by interferon-α involves a membrane-associated tyrosine phosphatase and tyrosine kinase. J. Biol. Chem. 268: 6593-6599, 1993.
18. David, M., L. Wong, R. Flavell, S. A. Thompson, A. Wells, A. C. Larner, and G. R. Johnson. STAT activation by epidermal growth factor (EGF) and amphiregulin. Requirement for the EGF receptor kinase but not for tyrosine phosphorylation sites or JAK1. J. Biol. Chem. 271: 9185-9188, 1996.